IBDEI119 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16792,2)
 ;;=^5063758
 ;;^UTILITY(U,$J,358.3,16793,0)
 ;;=Z99.81^^61^776^150
 ;;^UTILITY(U,$J,358.3,16793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16793,1,3,0)
 ;;=3^Supplemental Oxygen Dependence
 ;;^UTILITY(U,$J,358.3,16793,1,4,0)
 ;;=4^Z99.81
 ;;^UTILITY(U,$J,358.3,16793,2)
 ;;=^5063760
 ;;^UTILITY(U,$J,358.3,16794,0)
 ;;=Z98.1^^61^776^2
 ;;^UTILITY(U,$J,358.3,16794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16794,1,3,0)
 ;;=3^Arthrodesis Status
 ;;^UTILITY(U,$J,358.3,16794,1,4,0)
 ;;=4^Z98.1
 ;;^UTILITY(U,$J,358.3,16794,2)
 ;;=^5063734
 ;;^UTILITY(U,$J,358.3,16795,0)
 ;;=Z94.7^^61^776^8
 ;;^UTILITY(U,$J,358.3,16795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16795,1,3,0)
 ;;=3^Corneal Transplant Status
 ;;^UTILITY(U,$J,358.3,16795,1,4,0)
 ;;=4^Z94.7
 ;;^UTILITY(U,$J,358.3,16795,2)
 ;;=^5063661
 ;;^UTILITY(U,$J,358.3,16796,0)
 ;;=Z83.511^^61^776^23
 ;;^UTILITY(U,$J,358.3,16796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16796,1,3,0)
 ;;=3^Family Hx of Glaucoma
 ;;^UTILITY(U,$J,358.3,16796,1,4,0)
 ;;=4^Z83.511
 ;;^UTILITY(U,$J,358.3,16796,2)
 ;;=^5063382
 ;;^UTILITY(U,$J,358.3,16797,0)
 ;;=Z80.52^^61^776^26
 ;;^UTILITY(U,$J,358.3,16797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16797,1,3,0)
 ;;=3^Family Hx of Malig Neop of Baldder
 ;;^UTILITY(U,$J,358.3,16797,1,4,0)
 ;;=4^Z80.52
 ;;^UTILITY(U,$J,358.3,16797,2)
 ;;=^5063352
 ;;^UTILITY(U,$J,358.3,16798,0)
 ;;=Z80.51^^61^776^29
 ;;^UTILITY(U,$J,358.3,16798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16798,1,3,0)
 ;;=3^Family Hx of Malig Neop of Kidney
 ;;^UTILITY(U,$J,358.3,16798,1,4,0)
 ;;=4^Z80.51
 ;;^UTILITY(U,$J,358.3,16798,2)
 ;;=^321159
 ;;^UTILITY(U,$J,358.3,16799,0)
 ;;=Z83.41^^61^776^36
 ;;^UTILITY(U,$J,358.3,16799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16799,1,3,0)
 ;;=3^Family Hx of Mult Endocrine Neoplasia Syndrome
 ;;^UTILITY(U,$J,358.3,16799,1,4,0)
 ;;=4^Z83.41
 ;;^UTILITY(U,$J,358.3,16799,2)
 ;;=^5063380
 ;;^UTILITY(U,$J,358.3,16800,0)
 ;;=Z81.8^^61^776^43
 ;;^UTILITY(U,$J,358.3,16800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16800,1,3,0)
 ;;=3^Family Hx of Substance Abuse/Dependence,Psychoactive
 ;;^UTILITY(U,$J,358.3,16800,1,4,0)
 ;;=4^Z81.8
 ;;^UTILITY(U,$J,358.3,16800,2)
 ;;=^5063363
 ;;^UTILITY(U,$J,358.3,16801,0)
 ;;=Z81.4^^61^776^44
 ;;^UTILITY(U,$J,358.3,16801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16801,1,3,0)
 ;;=3^Family Hx of Substance Abuse/Dependence NEC
 ;;^UTILITY(U,$J,358.3,16801,1,4,0)
 ;;=4^Z81.4
 ;;^UTILITY(U,$J,358.3,16801,2)
 ;;=^5063362
 ;;^UTILITY(U,$J,358.3,16802,0)
 ;;=Z98.0^^61^776^55
 ;;^UTILITY(U,$J,358.3,16802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16802,1,3,0)
 ;;=3^Intestinal Bypass/Anastomosis Status
 ;;^UTILITY(U,$J,358.3,16802,1,4,0)
 ;;=4^Z98.0
 ;;^UTILITY(U,$J,358.3,16802,2)
 ;;=^5063733
 ;;^UTILITY(U,$J,358.3,16803,0)
 ;;=Z91.128^^61^776^54
 ;;^UTILITY(U,$J,358.3,16803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16803,1,3,0)
 ;;=3^Intentional Underdose of Meds d/t Other Reasons
 ;;^UTILITY(U,$J,358.3,16803,1,4,0)
 ;;=4^Z91.128
 ;;^UTILITY(U,$J,358.3,16803,2)
 ;;=^5063613
 ;;^UTILITY(U,$J,358.3,16804,0)
 ;;=Z77.120^^61^776^60
 ;;^UTILITY(U,$J,358.3,16804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16804,1,3,0)
 ;;=3^Mold (Toxic) Contact/Exposure
 ;;^UTILITY(U,$J,358.3,16804,1,4,0)
 ;;=4^Z77.120
 ;;^UTILITY(U,$J,358.3,16804,2)
 ;;=^5063318
